Support teaching, research, and patient care.
My projects focus on clinical research in newborns with, or at risk, for brain injury. I use EEG in at-risk neonates to better understand the underlying pathophysiology of risk factors that may lead to worse outcomes. I am particularly interested in neonatal seizures and how they may exacerbate perinatal brain injury with a goal to identify treatments that might protect the vulnerable brain. I am also interested in EEG in other pediatric populations, as well as medical ethics and global health.
Neonatal Seizure Registry - Developmental Functional EValuation
The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry
participants that aims to evaluate childhood outcomes after acute symptomatic neonatal
seizures, as well as examine risk factors for developmental disabilities and whether these
are modified by parent well-being.
View full details
High-dose Erythropoietin for Asphyxia and Encephalopathy
Hypoxic-ischemic encephalopathy (HIE) occurs when a baby gets reduced blood flow and oxygen
to the brain near the time of birth. This results in death or neurologic disabilities
including cerebral palsy and cognitive impairment in up to half of affected infants. This
clinical trial will determine if the drug erythropoietin (Epo) added to hypothermia (usual
therapy) will improve outcomes for infants suffering from HIE.
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .